Peiwu Li
- Gastroenterology top 5%
- Gastrointestinal motility and disorders 3
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 5
- Pharmacology top 10%
-
- RNA modifications and cancer 6
-
- Helicobacter pylori-related gastroenterology studies 6
- Pancreatitis Pathology and Treatment 5
-
- Ferroptosis and cancer prognosis 8
- Gastric Cancer Management and Outcomes 4
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Peiwu Li
36 papers receiving 647 citations
Peers
Comparison fields: 5 of 90
- Gastroenterology 97
- Cancer Research 175
- Pharmacology 45
- Molecular Biology 309
- Surgery 173
Countries citing papers authored by Peiwu Li
This map shows the geographic impact of Peiwu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiwu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiwu Li more than expected).
Fields of papers citing papers by Peiwu Li
This network shows the impact of papers produced by Peiwu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiwu Li. The network helps show where Peiwu Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peiwu Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 17 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 0 | |
| 7 | 2022 | 36 | |
| 8 | 2022 | 16 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 8 | |
| 12 | 2020 | 29 | |
| 13 | 2020 | 30 | |
| 14 | 2020 | 11 | |
| 15 | 2019 | 3 | |
| 16 | 2019 | 40 | |
| 17 | 2018 | 2 | |
| 18 | 2018 | 21 | |
| 19 | 2017 | 67 | |
| 20 | 2013 | 1 |
About Peiwu Li
Peiwu Li is a scholar working on Cancer Research, Gastroenterology and Complementary and alternative medicine, having authored 37 papers that have together received 659 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), Ferroptosis and cancer prognosis (8 papers), Helicobacter pylori-related gastroenterology studies (6 papers), RNA modifications and cancer (6 papers), MicroRNA in disease regulation (5 papers), Pancreatitis Pathology and Treatment (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Gastrointestinal motility and disorders (3 papers). The work is most often cited by research in Gastroenterology (97 citations), Cancer Research (175 citations) and Pharmacology (45 citations). Peiwu Li has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Fengbin Liu, Qiuke Hou, Fengbin Liu, Yongquan Huang, Xinlin Chen, Zhengkun Hou, Changrong Zhang, Yi Wen, Kechao Nie and Zhihua Zheng. Their work appears in journals such as BMC Genomics, Genomics and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.